Enlivex Therapeutics Ltd. (ENLV)
NASDAQ·Healthcare·Biotechnology
$2.06
-5.07%
Mkt Cap $28.19M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+628.2%
Consensus $15.00 vs current $2.06
NASDAQ·Healthcare·Biotechnology
$2.06
-5.07%
Mkt Cap $28.19M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+628.2%
Consensus $15.00 vs current $2.06